In addition, a high tumor Ki-67 index combined with a high tumor gC1qR H score, portended the worst OS, indicating the beneficial role of both Ki-67 and gC1qR as markers in stratifying benefit from chemotherapy. Here, MKI67 is linked to neoplasm.